Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery
PREVEMCA
1 other identifier
interventional
378
1 country
3
Brief Summary
The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration in the anesthetic consultation in the prevention of medical errors perioperatively in patients undergoing scheduled surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2019
CompletedFirst Posted
Study publicly available on registry
July 9, 2019
CompletedStudy Start
First participant enrolled
February 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedDecember 11, 2025
March 1, 2022
1.5 years
July 5, 2019
December 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of patients with at least one medication error for chronic treatment
%
48 hours post-admission
Secondary Outcomes (8)
Nature of medication error
48 hours post-admission
Rate of medication errors corrected
48 hours post-admission
Rate of prescriptions respecting the Société Française d'Anesthésie et de Réanimation recommendations
48 hours post-admission
Rate of corrected medication errors or major, critical or catastrophic severity according to HAS 2018
48 hours post-admission
Rate of patients whose usually prescribed medication at admission is not available for them in the evening following surgery
48 hours post-admission
- +3 more secondary outcomes
Study Arms (2)
Standard consultation
NO INTERVENTIONPharmacist-anesthesiologist consultation
EXPERIMENTALInterventions
Pharmacist-anesthesiologist team will be present during the anesthetic consultation
Eligibility Criteria
You may qualify if:
- The patient must have given their free and informed consent
- The patient must be a member or beneficiary of a health insurance plan
- The patient has at least one chronic medication prescription (associated with a chronic illness)
- The patient is hospitalized for a programmed surgery in the service of urology or digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse
You may not qualify if:
- The subject refuses to sign the consent
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- The patient is having ambulatory programmed surgery
- The patient has an anesthetic consultation in a different health establishment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
CHU de Montpellier
Montpellier, 34090, France
CHU de Nimes
Nîmes, 30029, France
CHU de Toulouse
Toulouse, France
Study Officials
- STUDY DIRECTOR
Géraldine Leguelinel-Blache
CHU Nimes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2019
First Posted
July 9, 2019
Study Start
February 25, 2020
Primary Completion
August 20, 2021
Study Completion
September 30, 2021
Last Updated
December 11, 2025
Record last verified: 2022-03